Skip to main content
logo
Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.700
-0.070 (-2.53%)
At close: Jul 7, 2026, 4:00 PM EDT
2.611
-0.090 (-3.31%)
After-hours: Jul 7, 2026, 6:54 PM EDT

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $21.58 million as of July 7, 2026. Its market cap has increased by 61.03% in one year.

Market Cap
21.58M
Enterprise Value
14.76M
1-Year Change
61.03%
Ranking
#4977
Category
Nano-Cap
Stock Price
$2.70

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $21.58M, an increase of 187.71%. That is a compound annual growth rate of 5.25%.

History

DateMarket Cap% Change
Jul 7, 202621.58M72.62%
Dec 31, 202512.50M1.63%
Dec 31, 202412.30M-63.82%
Dec 29, 202334.00M112.50%
Dec 30, 202216.00M-60.59%
Dec 31, 202140.60M-27.24%
Dec 31, 202055.80M164.45%
Dec 31, 201921.10M185.14%
Dec 31, 20187.40M-65.90%
Dec 29, 201721.70M233.85%
Dec 30, 20166.50M3.17%
Dec 31, 20156.30M-73.08%
Dec 31, 201423.40M9.86%
Dec 31, 201321.30M-37.72%
Dec 31, 201234.20M187.39%
Dec 30, 201111.90M325.00%
Dec 31, 20102.80M-98.80%
Dec 31, 2009233.20M2,164.08%
Dec 31, 200810.30M-56.90%
Dec 31, 200723.90M-22.90%
Dec 29, 200631.00M-30.49%
Dec 30, 200544.60M494.67%
Nov 10, 20057.50M-
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
NeuroSense Therapeutics25.03M
Skye Bioscience24.62M
Marker Therapeutics24.51M
Tevogen Bio Holdings24.16M
Pluri22.77M
VYNE Therapeutics22.68M
Longeveron21.51M
Quantum BioPharma21.40M
Market Cap Rankings